嘉兴中润光学科技股份有限公司章程 第一章 总则 嘉兴中润光学科技股份有限公司 章程 二〇二五年十月 | 第二章 | 经营宗旨和范围 4 | | | --- | --- | --- | | 第三章 | 股份 | 4 | | 第一节 | 股份发行 | 4 | | 第二节 | 股份增减和回购 | 7 | | 第三节 | 股份转让 | 9 | | 第四章 | 股东和股东会 | 9 | | 第一节 | 股东 | 9 | | 第二节 | 控股股东和实际控制人 12 | | | 第三节 | 股东会的一般规定 13 | | | 第四节 | 股东会的召集 | 17 | | 第五节 | 股东会的提案与通知 19 | | | 第六节 | 股东会的召开 | 20 | | 第七节 | 股东会的表决和决议 23 | | | 第五章 | 董事会 | 27 | | 第一节 | 董事的一般规定 27 | | | 第二节 | 董事会 | 31 | | 第三节 | 独立董事 | 36 | | 第四节 | 董事会专门委员会 39 | | | 第六章 | 经理及其他高级管理人员 41 | | | 第七章 | 财务会计制度、利润分配和审计 43 | | ...

Core Viewpoint - The company, Jiaxing Zhongrun Optical Technology Co., Ltd., is set to hold a Q3 2025 performance briefing on November 3, 2025, to discuss its operational results and financial status with investors [2][3]. Group 1: Meeting Details - The performance briefing will take place on November 3, 2025, from 15:00 to 16:00 [4]. - The meeting will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [4][5]. - Investors can submit questions from October 27 to October 31, 2025, through the Roadshow Center website or via the company's email [2][5]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [4]. - The company will address commonly asked questions during the briefing, ensuring transparency and engagement with investors [3][5].

证券代码：688307 证券简称：中润光学 公告编号：2025-056 嘉兴中润光学科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 嘉兴中润光学科技股份有限公司（以下简称"公司"）将于 2025 年 10 月 31 日发布公 司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营 成果、财务状况，公司计划于 2025 年 11 月 03 日(星期一)下午 15:00-16:00 举行 2025 年第 三季度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2025 年第三季度的经营成果及财 务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内就投资者普遍 关注的问题进行回答。 二、 说明会召开的时间、地点 会议召开时间：2025 年 11 月 03 日(星期一) 下午 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址 ...

Market Overview - On October 21, the Shanghai Composite Index rose by 1.36%, the CSI 300 increased by 1.53%, the STAR 50 climbed by 2.81%, the CSI 1000 went up by 1.45%, the ChiNext Index surged by 3.02%, and the Hang Seng Index gained 0.65% [6] - The best-performing sectors on October 21 were telecommunications (+4.9%), electronics (+3.5%), construction decoration (+2.36%), comprehensive (+2.29%), and real estate (+2.25%). The worst-performing sectors included coal (-1.02%), food and beverage (+0.23%), transportation (+0.29%), beauty and personal care (+0.31%), and banking (+0.33%) [6] - The total trading volume for the A-share market on October 21 was 1,892.693 billion yuan, with a net inflow of 1.171 billion Hong Kong dollars from southbound funds [6] Key Recommendations - The report highlights Zhongrun Optical (688307) as a leading domestic brand in high-magnification optical zoom lenses, expanding into new fields such as drones and mobile robots. The company is expected to double its performance due to industry growth and increased market share from domestic replacements [7][8] - The report argues against the prevailing market view that new downstream products will only provide temporary boosts to the optical lens industry, asserting that the long-term outlook remains positive due to factors such as import substitution and the company's unique technological capabilities [7] - The target price for Zhongrun Optical is set at 66.27 yuan, with projected revenues of 660 million yuan, 1,170 million yuan, and 1,645 million yuan for 2025-2027, reflecting growth rates of 45%, 77%, and 44% respectively [8] Important Insights - The macroeconomic report anticipates a slight decline in economic growth to 4.7% in the fourth quarter, with an overall growth target of around 5% for the year, despite challenges [10] - The report emphasizes that there may be additional stimulus policies in the fourth quarter, with significant measures potentially being reserved for the first quarter of the following year to ensure a strong start [10] Industry Analysis - The medical device industry is expected to see accelerated innovation and international expansion, particularly in areas such as cardiac intervention, biological materials, and surgical robots. Companies like United Imaging Healthcare and Mindray Medical are highlighted as key players [11] - The report identifies catalysts for growth in the medical device sector, including moderate price reductions, the recovery of tenders, and the acceleration of new product launches [11]

Core Insights - On October 20, a total of 36 stocks received buy ratings from brokerages, with 7 stocks announcing target prices [1] - Based on the highest target prices, Zhongrun Optical, Huayou Cobalt, and Shenhuo Co. ranked highest in target price increase potential, with expected increases of 76.25%, 56.95%, and 46.65% respectively [1] - Among the rated stocks, 32 maintained their ratings, while 4 received their first ratings [1] - Five stocks attracted attention from multiple brokerages, with Chunfeng Power, Huayou Cobalt, and Fuyao Glass receiving the most ratings, at 3, 2, and 2 brokerages respectively [1] - In terms of industry distribution, the Materials II, Automotive and Auto Parts, and Capital Goods sectors had the highest number of stocks with buy ratings, totaling 13, 6, and 4 respectively [1]

Core Viewpoint - The company is a leading brand in domestic medium and large zoom lenses and one of the few suppliers of industrial drone lenses, benefiting from industry scale growth and market share increase, with potential for performance to double. Group 1: Industry Growth and Opportunities - Short-term growth driven by the rise of drones and smart robots, with drones opening a second growth curve due to new application scenarios in consumer, industrial, and military fields, where lenses are core components, and the company holds a 5.6% market share in 2021 [1] - The demand for laser radar is increasing due to the spatial perception needs of mobile robots, with the company expanding into household, service, collaborative, AMR, and humanoid robots [1] - Long-term prospects indicate that the optical lens industry will undergo a new round of transformation driven by the rapid development of emerging fields like embodied intelligence [1] Group 2: Digital Security Lens Demand - The demand for medium and large zoom lenses in the digital security sector is growing, despite a temporary slowdown in overall growth, driven by applications in border defense, rail transportation, and river monitoring [2] - The company has a strong technical foundation from its partnership with Kinoshita Optical, which has over 40 years of lens development history and provides services to renowned international companies [2] Group 3: Strategic Investments and Acquisitions - The company plans to acquire 51% of Dais Optoelectronics by mid-2025, focusing on precision optical components for laser devices, semiconductor equipment testing, and autonomous driving, with net profit commitments of 0.21, 0.29, and 0.40 billion yuan from 2025 to 2027 [2] - Investment in 45% of Blue Star Guangyu through its subsidiary Runyang Fund is also planned, targeting the domestic leading supplier of space optical communication payloads for low-orbit satellite communication and drone applications [2] Group 4: Financial Forecast and Valuation - The company is expected to achieve net profits of 0.6, 1.7, and 2.5 billion yuan from 2025 to 2027, with year-on-year growth rates of 19%, 164%, and 51% respectively, corresponding to PE ratios of 52, 20, and 13 times [3] - The company is actively expanding into emerging downstream fields, indicating significant performance elasticity, with a target price of 66.27 yuan based on a 35 times PE for 2026, initiating coverage with a "buy" rating [3]

Core Viewpoint - Zhongrun Optical announced a cash dividend distribution plan for the first half of 2025, proposing a cash dividend of 0.1 yuan per share (including tax) [1] Summary by Category - **Dividend Announcement** - The cash dividend of 0.1 yuan per share is set to be distributed [1] - The record date for the dividend is October 22, 2025, and the ex-dividend date is October 23, 2025 [1]

证券代码：688307 证券简称：中润光学 公告编号：2025-055 嘉兴中润光学科技股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0.1元（含税） 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/10/22 | 2025/10/23 | 2025/10/23 | 一、通过分配方案的股东会届次和日期 二、分配方案 1.发放年度：2025年半年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海 分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3.分配方案： 本次利润分配以方案实施前的公司总股本88,774,000股为基数，每股派发现金红利0.1 元（含税），共计派发现金红利8,877,400元。 三、相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | ...

Market Performance - The photolithography concept sector declined by 2.47%, ranking among the top losers in the market, with major declines from companies like United Chemical (down 20%), Maolai Optical, and Nanjing Chemical Fiber [1] - Among the concept stocks, only five saw price increases, with Zhongrun Optical, Zhongguang Lightning Protection, and Juguang Technology rising by 5.32%, 4.25%, and 0.87% respectively [1][3] Capital Flow - The photolithography concept sector experienced a net outflow of 1.239 billion yuan, with 37 stocks seeing net outflows, and five stocks exceeding 100 million yuan in outflows [1] - The stock with the highest net outflow was Xinlai Material, with a net outflow of 222.94 million yuan, followed by United Chemical, Kaimete Gas, and Zhangjiang Hi-Tech with net outflows of 170.13 million yuan, 162.39 million yuan, and 150.41 million yuan respectively [1][2] Top Gainers and Losers - The top gainers in the photolithography concept included Zhongrun Optical (up 5.32%), Zhongguang Lightning Protection (up 4.25%), and Juguang Technology (up 0.87%) [1][3] - The top losers included United Chemical (down 20%), Maolai Optical (down 6.38%), and Nanjing Chemical Fiber (down 6.19%) [1][2]

Group 1 - The second board meeting of Jiaxing Zhongrun Optical Technology Co., Ltd. was held on October 9, 2025, with all seven directors present, and the meeting was deemed legally valid [2][4] - The board approved the election of Zhang Pinghua as the representative director to execute company affairs and serve as the legal representative, with a term lasting until the end of the current board's term [3][4] - The board also approved the election of members for the audit committee, including Zhu Chaohui as the chairperson, ensuring compliance with relevant laws and regulations [5][6] Group 2 - The company announced the adjustment of its 2025 semi-annual profit distribution plan, increasing the total cash dividend from 8,800,000.00 yuan to 8,877,400.00 yuan due to an increase in the total share capital [14][16] - The cash dividend per 10 shares remains unchanged at 1.00 yuan (tax included), with no issuance of bonus shares or capital reserve conversion [14][16] - The adjustment was made following the completion of registration for 774,000 restricted stocks under the company's incentive plan, which increased the total share capital from 88,000,000 shares to 88,774,000 shares [14][16]